Latest S-1 registration statements

American Battery Materials, Inc. has filed an S-1/A registration statement to raise $15 million through a public offering of common stock, aiming to fund its Lisbon Valley Lithium Project and expand mineral rights, despite a history of recurring losses and substantial doubt about its ability to continue as a going concern.

CapsoVision, Inc., a medical technology company specializing in capsule endoscopy, is seeking to raise approximately $22.83 million in its initial public offering to fund product development and commercial expansion, despite a history of net losses and auditor-raised substantial doubt about its ability to continue as a going concern.

Imunon, a clinical-stage biotechnology company, is registering shares for resale by existing investors following a private placement, while simultaneously grappling with severe financial challenges, including multiple Nasdaq delisting notices and substantial doubt about its ability to continue as a going concern.

Mangoceuticals, Inc. has filed an S-1 registration statement to allow existing shareholders to resell up to 4,461,718 shares of common stock, while the company continues to report significant net losses and faces a lawsuit from Eli Lilly and Company.

Tvardi Therapeutics, formerly Cara Therapeutics, has completed its reverse merger, establishing itself as a clinical-stage biopharmaceutical company focused on developing novel oral small molecule therapies targeting STAT3 for fibrosis-driven diseases, including idiopathic pulmonary fibrosis and hepatocellular carcinoma.

Propanc Biopharma, Inc. has filed an amended S-1 registration statement to offer 1,000,000 shares of common stock and allow for the resale of 3,091,500 shares by existing stockholders, as the company grapples with a significantly increased net loss of $54.85 million and substantial doubt about its ability to continue as a going concern.

Functional Brands Inc. has filed an S-1/A amendment for a direct listing on the Nasdaq Capital Market, seeking to raise $8 million through a private placement to address a significant acquisition debt and fund growth, despite reporting recurring losses and a going concern warning from its auditors.

Nuwellis, Inc. has filed an S-1 registration statement to offer common stock and warrants, aiming to raise approximately $4.2 million for working capital and potential acquisition activities, despite ongoing operating losses and substantial doubt about its ability to continue as a going concern.

Pioneer Acquisition I Corp, a newly formed blank check company, is launching a $220 million initial public offering to seek a business combination with a target in the healthcare or healthcare-related industries within 24 months.

Galaxy Digital Inc. has filed an S-1MEF registration statement to increase its Class A common stock offering by 2,990,000 shares, including an underwriters' option, at a proposed maximum price of $19.00 per share.

Omada Health, Inc. has filed an S-1/A registration statement for its initial public offering of 7,500,000 shares of common stock, with an anticipated price range of $18.00 to $20.00 per share, aiming to raise approximately $133.2 million for general corporate purposes and potential acquisitions.

Idaho Copper Corporation has filed an amended registration statement for the resale of over 94 million shares by selling stockholders, highlighting its continued exploration and development efforts for the CuMo project amidst substantial financial losses and a critical need for future financing.

OSR Holdings, a global healthcare holding company, reported a significant increase in net loss and a decrease in net sales for Q1 2025, while securing new dilutive financing agreements to address liquidity challenges following a cancelled $20 million PIPE transaction.

Dror Ortho-Design, Inc., a development-stage company with no current revenues, has filed an S-1 registration statement to offer common stock and warrants, seeking to raise capital for its proprietary AI-based ZSmile orthodontic platform while facing substantial doubt about its ability to continue as a going concern.

Liberty Broadband is spinning off its subsidiary GCI Liberty, a telecommunications company operating primarily in Alaska, as a prerequisite to its merger with Charter Communications.

Galaxy Digital Inc. reported a significant net loss in the first quarter of 2025, driven by digital asset price declines, while actively progressing its strategic expansion into high-performance computing (HPC) data centers with key client commitments.

Galaxy Digital Inc. is undertaking a public offering of Class A common stock to fund the expansion of its artificial intelligence and high-performance computing infrastructure, while navigating a volatile digital asset market and ongoing regulatory developments.

Medicus Pharma Ltd., a clinical-stage biotech company, has filed an S-1 registration statement for a public offering of up to 1,375,000 units, aiming to raise approximately $10 million to fund its Phase 2 clinical trials for basal cell carcinoma and support general corporate purposes, despite ongoing operating losses and a 'going concern' warning from its auditor.

Bitmine Immersion Technologies, a blockchain technology company specializing in bitcoin mining and related services, has filed an S-1/A registration statement for a public offering of 1,875,000 common shares to fund bitcoin acquisitions and expand its mining infrastructure, despite a history of significant net losses.

General Enterprise Ventures, Inc. (GEVI), an environmentally sustainable flame retardant company, has filed an S-1/A registration statement for a public offering of 3,500,000 common shares and intends to list on NYSE American, despite reporting substantial net losses and a going concern qualification from its auditors.

Twelve Seas Investment Company III, a blank check company, filed an amended registration statement for its $150 million initial public offering, outlining its strategy to acquire non-U.S. companies while disclosing significant dilution risks for public shareholders and potential conflicts of interest involving its management team.

Medicus Pharma Ltd., a clinical-stage biotech company, has filed an S-1 registration statement to allow for the resale of up to 3.71 million common shares by a selling shareholder, while also disclosing significant operating losses, a going concern warning, and updates on its lead skin cancer drug candidate and a new acquisition.

Palisade Bio, a clinical-stage biopharmaceutical company, announced a public offering of common stock and pre-funded warrants to raise approximately $8.9 million, following positive Phase 1 clinical trial results for its lead IBD candidate, PALI-2108.

Circle Internet Group, Inc., the issuer of USDC, has filed an amended S-1 registration statement for its initial public offering, revealing significant revenue growth, expanding global partnerships, and continued innovation in the stablecoin and blockchain sectors.

Iron Horse Acquisitions Corp. II, a blank check company, filed an amended S-1 registration statement for its initial public offering of 20,000,000 units at $10.00 per unit, aiming to raise $200 million for a business combination primarily within the media and entertainment industry.

BEST SPAC I Acquisition Corp., a British Virgin Islands blank check company, filed an amended S-1 registration statement for its $55 million initial public offering, aiming to acquire a consumer goods business with an enterprise value between $100 million and $600 million, while disclosing significant risks related to its blank check nature and ties to China.

Jefferson Capital, Inc., a leading purchaser and manager of charged-off and insolvency consumer accounts, has filed an S-1/A registration statement for its initial public offering, highlighting robust financial performance, strategic acquisitions, and ambitious growth plans across its global operations.

Slide Insurance Holdings, Inc. has filed for an initial public offering, aiming to leverage its technology-driven platform and expertise in underserved coastal specialty insurance markets.

Caris Life Sciences, a leading AI TechBio company specializing in precision oncology, has filed for an initial public offering to raise capital for continued innovation and market expansion of its comprehensive molecular profiling solutions, despite significant and ongoing net losses.

Helius Medical Technologies, a neurotechnology company, has filed an S-1 registration statement for a public offering of common stock and warrants, seeking to raise approximately $13.6 million to address immediate financial needs and Nasdaq listing compliance, while facing substantial dilution for new investors.